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Abstract
The three transcription factors, PDX1, NGN3 and MAFA, are very important in pancreatic development.
Overexpression of these three factors can reprogram both pancreatic exocrine cells and SOX9-positive cells of the
liver into cells resembling pancreatic beta cells. In this study we investigate whether other cell types can be
reprogrammed. Eight cell types are compared and the results are consistent with the idea that reprogramming occurs
to a greater degree for developmentally related cells (pancreas, liver) than for other types, such as fibroblasts. Using
a line of mouse hepatocyte-derived cells we screened 13 compounds for the ability to increase the yield of
reprogrammed cells. Three are active and when used in combination they can increase the yield of insulin-
immunopositive cells by a factor of six. These results should contribute to the eventual ability to develop a new cure
for diabetes based on the ability to reprogram other cells in the body to a beta cell phenotype.
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Introduction
Diabetes mellitus is a life threatening metabolic disease the
prevalence of which is increasing worldwide [1]. It is
characterized by hyperglycemia due to an absolute lack of
insulin from pancreatic beta cells (Type 1 diabetes) or a relative
lack (Type 2 diabetes). Complications of diabetes such as
cardiovascular diseases, retinopathy, neuropathy,
nephropathy, and peripheral circulatory diseases depend on
imperfect regulation of blood sugar and can be lethal if they are
not treated. Despite its good effectiveness, the therapy
provided by insulin injections cannot reproduce the normal
insulin secretion pattern as efficiently as beta cells. Beta cell
transplantation is effective to some degree but the shortage of
cadaveric pancreases is a major limitation, and immune
suppression is necessary, which causes side effects and
toxicity to the graft [2]. These limitations could potentially be
overcome by reprogramming of other cells within the body of
the patient into insulin-expressing, glucose-sensitive beta-like
cells [3]. Production of new beta cells from highly regenerative
organs such as liver or from organs in which alteration of some
cells does not affect the overall function, such as the exocrine
pancreas, would also solve the problem of the shortage of cells
for transplantation. Based on this possibility, many studies
regarding beta cell reprogramming have been performed in
liver cells both in vivo and in vitro. Recently, overexpression of
Pdx1, Ngn3 and MafA in the exocrine pancreas of mouse was
shown to produce insulin-positive cells which were capable of
rescuing RAG1-/- mice made diabetic by treatment with
streptozotocin [4]. We have followed up this study using a
single adenovector encoding all three factors. Our study on the
rat AR42j-B13 cell line, which has a pancreatic exocrine
phenotype, indicated that the transformation is reproducible
and stable, but does not confer all the beta cell properties,
especially the critical property of glucose-sensitivity [5].
Recently we showed that the same gene combination was able
to induce the formation of insulin-secreting, glucose-sensitive
ductal structures in the livers of immunodeficient mice, and the
cell of origin was identified as a SOX9-positive population,
either small bile ducts or perhaps bipotential progenitor cells
located in the periportal regions of the liver [6]. In this case the
reprogrammed cells were glucose-sensitive. The combination
Pdx1, Ngn3 and MafA (here abbreviated to PNM) represents a
logical gene set for stimulating pancreatic endocrine
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e82424
development. In the normal embryo Pdx1 is required for
pancreatic bud outgrowth, Ngn3 for endocrine precursor cell
formation, and MafA (and Pdx1 again), for beta-cell maturation
[7].
In the current study we have extended our understanding of
PNM effects in two respects. First we have looked at the
reprogramming competence of various different cell types. The
cells we used were mouse hepatocyte-derived small cells (ASH
cells), mouse primary hepatocytes, mouse embryonic
fibroblasts (MEF) and mouse adult (tail tip) fibroblasts, rat
primary hepatocytes, rat pancreatic exocrine cells (AR42J-
B13), rat adult fibroblasts (CRL-1213) and rat multipotent adult
progenitor cells (MAPC). The results are consistent with the
idea that reprogramming occurs to a greater degree for
developmentally related cells (pancreas, liver) than for
fibroblasts.
Secondly, we have investigated the effect of a panel of small
molecules which are candidates for improving reprogramming
efficiency, together with the three transcription factors. For this
we used the mouse hepatocyte-derived small cells, which
normally show a reproducible but low percentage of
transformation. We found three substances: DAPT, an
antagonist of Notch signaling, NECA, an adenosine agonist,
and BIX-01294, an inhibitor of histone deacetylases, each of
which individually increases reprogramming to some degree
and together do so by a factor of 6. We expect these
substances to be useful for reprogramming procedures in the
future.
Materials and Methods
Cell Culture and Viral Transfection
Mouse hepatocyte-derived small cells (ASH cells) were
derived from primary mouse hepatocytes of a mouse of
AlbCre;R26R genotype, and are known by the abbreviation
ASH (="AlbCre small hepatocytes”). The hepatocytes were
isolated at the University of Bath using the two step
collagenase perfusion method [8]. This is a non-survival
procedure conducted under anesthesia. The work was
conducted under Home Office Project Licence PPL30/2004
"Transdifferentiation of Rodent Tissues" granted to JMWS. The
cells were maintained in low-glucose Dulbecco`s Modified
Eagles medium (DMEM; Gibco) supplied with 10% (v/v) fetal
bovine serum (FBS; Hyclone) and 1x antibiotic-antimycotic
solution (anti-anti; Gibco). Because they are derived from
albumin-positive precursors they express the β-geo marker,
although this was not used in the present work. Their small size
and rapid growth rate may indicate a "progenitor-like" status,
although their exact in vivo counterpart is not known.
Mouse embryonic fibroblasts (MEF) were isolated in the
laboratory from prenatal mouse embryos. The pregnant
females were sacrificed by the approved method of CO2
overdose under University of Minnesota IACUC Protocol
1002A78295 "Directed Transdifferentiation of Rodent Tissues"
granted to JMWS. Cells were maintained in high-glucose
DMEM supplied with 10% (v/v) FBS, 2mM L-glutamine (Gibco)
and 1x anti-anti solution.
Mouse adult fibroblasts were obtained in the laboratory by
culturing a piece of tail tip from an adult mouse in vitro. The
mouse was sacrificed by the approved method of CO2
overdose under University of Minnesota IACUC Protocol
1002A78295 "Directed Transdifferentiation of Rodent Tissues"
granted to JMWS. The fibroblasts were maintained in high-
glucose DMEM supplied with 10% (v/v) FBS, 2mM L-glutamine
and1x anti-anti solution.
Rat and mouse primary hepatocytes were isolated from adult
male rats and mice by the two-step collagenase perfusion
method [8] under University of Minnesota IACUC Protocol
1002A78295 "Directed Transdifferentiation of Rodent Tissues"
granted to JMWS. After the isolation they were cultured in
Williams' E medium (Gibco) supplied with 10% (v/v) FBS, 2mM
L-glutamine, 1x anti-anti and gentamycin solution (Gibco) for
overnight for attachment to plate. After the cells attached to the
plate they were maintained in low-glucose DMEM supplied with
10% (v/v) FBS, 2mM L-glutamine and 1x anti-anti solution.
Rat pancreatic exocrine-like cells (AR42J-B13), which were
originally derived from a chemically induced pancreatic tumor
[9], were obtained from Dr David Tosh (University of Bath, UK)
and maintained in low-glucose DMEM supplied with 10% (v/v)
FBS, 2mM L-glutamine and 1x anti-anti solution.
Rat adult fibroblast cells (CRL-1213) were purchased from
ATCC. They were maintained in high-glucose DMEM supplied
with 10% (v/v) FBS, 2mM L-glutamine and 1x anti-anti solution.
Rat multipotent adult progenitor cells (MAPC) were obtained
from Dr Wei-Shou Hu`s Laboratory (University of Minnesota,
MN). These cells originate from adult bone marrow but have
some properties of embryonic stem cells [10]. They were
maintained in low-glucose DMEM and MCDB media (Sigma)
supplied with 2% (v/v) FBS, 1x anti-anti solution, 1x ITS
(Insulin/Transferrin/Selenium; Sigma), 1mg/ml LA-BSA
(Linoleic acid-bovine serum albumin; Sigma), 1x L-ascorbic
acid, 0.5µM dexamethasone, 10ng/ml PDGF (Platelet-derived
growth factor; Sigma), 10ng/ml EGF (Epidermal growth factor;
Millipore), 0.01x LIF (Leukemia inhibitory factor; Millipore) and
0.1x β-mercaptoethanol (Gibco).
An adenovector (Ad-PNM) carrying mouse Pdx1, Ngn3 and
MafA in a single transcription unit, separated by 2A sequences,
was prepared as described previously [5]. Preliminary trials
showed that a multiplicity of infection (MOI) of 25 gave
maximum insulin-positive cells with minimum toxicity so this
dose was adopted as the standard for the study. Next day the
virus-containing medium was replaced. Three days after virus
transduction, total RNA was isolated for reverse transcription-
polymerase chain reaction (RT-PCR) and the cells were also
fixed for immunostaining to see how they had responded. The
Ad-PNM infection efficiency was calculated for each cell type to
ensure it was sufficient to give reliable results. The efficiency
was obtained by counting all the cells in three fields of vision
and taking an average percentage of the cell population
showing nuclear PDX1 immunostaining.
Reverse Transcription-Polymerase Chain Reaction (RT-
PCR)
Total RNA from the cells was isolated using the RNeasy Mini
Kit (Qiagen). RNA samples were then treated with DNase
Reprogramming to a Beta-Like State
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enzyme (Promega) to remove possible genomic DNA
contamination. cDNAs were then synthesized by reverse
transcription from 2μg total RNA using SuperScript III Reverse
Transcriptase, oligo(dT)20 and dNTP (10mM) (Invitrogen). The
gene expression pattern between the cells with and without Ad-
PNM was then compared by performing PCR. After an initial
denaturation at 94°C for 3 min, reaction mixtures were
subjected to 20-35 cycles of amplification using the following
conditions: 94°C 30 s denaturation, 60°C 30 s annealing, 72°C
1 min extension, 72°C 5 min final extension. PCR products
were then run on 1% (w/v) agarose gel (Invitrogen), in TAE
(Tris-Acetic Acid-EDTA) buffer (Bio-Rad Laboratories) including
ethidium bromide, by electrophoresis at 100V. Gels were
visualized with a Bio-Rad Gel Documentation System model
2000. Primer sequences are available on request. For these
experiments the negative control was water. The positive
control was whole pancreas RNA for markers expressed in
pancreas. For other markers it was as follows: whole liver RNA
for Alb, embryonic liver bud RNA for Afp, mouse and rat adult
fibroblast RNA for Vim, rat RNA for Oct4, donated by the lab of
Dr Hu (UofM).
Quantitative Reverse Transcription–Polymerase Chain
Reaction (qRT-PCR)
Total RNA isolation and cDNA synthesis were performed as
described above. The gene expression pattern between the
cells with and without Ad-PNM was then compared by
performing qRT–PCR. After an initial denaturation at 95°C for
30 s, reaction mixtures were subjected to 40 cycles of
amplification using the following conditions: 95°C for 5 s
denaturation, and 60°C for 10 s annealing and extension.
Primer sequences are available on request. The expression
levels of the genes of interest were expressed relative to
transcripts of the gene for the ubiquitous enzyme
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which
was normalized to zero.
Immunostaining
The cells were fixed with 4% (w/v) paraformaldehyde
(Sigma) in PBS (phosphate buffered saline; Sigma) for 20 min.
After fixation cells were washed three times with 0.1% (v/v)
Tween 20 (Bio-Rad) in PBS (PBS-T) for 5 min in each wash.
Cells were then permeabilized with 0.2% (v/v) Triton X-100
(Sigma) in PBS for 15 min. After 1 hr blocking with PBS-T
including 1% (w/v) BSA (Bovine serum albumin; Sigma), cells
were incubated overnight with primary antibody at 4°C and
then 1 hr with secondary antibody at room temperature.
Primary antibodies used were as follows: guinea pig anti-insulin
(1:200, Sigma); rabbit anti-PDX1 (1:2000, Upstate); rabbit anti-
C-peptide (1:100, Cell Signaling), rabbit anti-NGN3 (1:100,
Santa Cruz Biotechnology); rabbit anti-MAFA (1:100, Santa
Cruz Biotechnology). Secondary antibodies used were as
follows: alexa fluor 480 goat anti-rabbit IgG (1:500, Invitrogen)
and alexa fluor 594 goat anti-guinea pig IgG (1:500,
Invitrogen). Images were taken using a Leica DMI6000 B
inverted microscope.
Administration of Small Molecules with Ad-PNM
105 mouse hepatocyte-derived small cells (ASH cells) were
plated into each well of 6-well plates (Day 0). The cells were
allowed to attach overnight. The next day each substance was
individually given to the cells in different wells at the final
concentrations mentioned below (Day 1). After two days
incubation, the number of the cells per well was calculated and
15 MOI Ad-PNM was given without removing the substances
from the medium (Day 3). The next day, both Ad-PNM and the
substance-containing medium was removed (Day 4). The cells
were maintained in the culture for two more days before
analysis.
The substances were: trichostatin A (TSA), valproic acid
(VPA), suberoylanilide hydroxamic acid (SAHA), BIX-01294, 5-
azacytosine (5-AzaC), pirinixic acid (WY-14643), N-[N-(3,5-
difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester
(DAPT), mycophenolic acid (MPA), 5'-N-
ethylcarboxamidoadenosine (NECA), nicotinamide, retinoic
acid (RA), disulfiram (tetraethylthiuram disulphide) and
diethylaminobenzaldehyde (DEAB).
Concentrations used were as follows: 1 mM for TSA (Sigma,
diluted in dH2O), 1 mM for VPA (Sigma, diluted in dH2O), 5 μM
for SAHA (Sigma, diluted in DMSO), 2 μM for BIX (Tocris,
diluted in dH2O), 5 μM for 5-AzaC (Sigma, diluted in DMSO),
75 μM for WY-14643 (Cayman, diluted in DMSO), 10 μM for
DAPT (Sigma, diluted in DMSO), 1 μM for MPA (Sigma, diluted
in DMSO), 10 μM for NECA (Tocris, diluted in DMSO), 5 mM
for nicotinamide (Sigma, diluted in dH2O), 100 nm for disulfiram
(Sigma, diluted in DMSO), 10 μM for DEAB (Aldrich, diluted in
DMSO), 10 μM for RA (Sigma, diluted in DMSO).
To see if the small molecules increase the reprogramming
efficiency of Ad-PNM, we counted the number of insulin-
expressing cells. For this purpose, the cells were fixed and
immunostained for insulin and PDX1 (Day 6). The number of
insulin-positive cells as a fraction of PDX1-positive cells was
calculated by counting ten randomly chosen different areas in
each well. Three different wells were counted for each
experimental group and two different experiments were set up
at different times. One way ANOVA tests were used to make
statistical comparisons.
ELISA for glucose-stimulated insulin release
5x105 cells were plated in each well of a six-well plate. The
medium was removed and cells were incubated in Krebs
Ringer Buffer (KRB) without glucose for two hours at 37°C.
They were then exposed to 2.8 mM or 20 mM glucose in KRB
for 1 hour at 37°C. The medium was then removed and kept at
-20°C for measurement of secreted insulin using an
Ultrasensitive Insulin ELISA kit (Mercodia) according to the
manufacturer's manual. One way ANOVA with Tukey posthoc
tests and additional t tests were used to make statistical
comparisons.
For measurement of insulin content, the cells were detached
with trypsin and resuspended in KRB. A sample was used for a
total protein measurement with the Pierce BCA Protein Assay
kit (Thermo Scientific). After homogenization using an insulin
syringe, the cells, with protease inhibitors, were rotated
overnight at 4°C and centrifuged (12000 rpm, 5 min at 4°C).
Reprogramming to a Beta-Like State
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Then the supernatant was collected and the insulin
concentration was measured as above.
Results
A total of eight different cell types from rat and mouse were
treated with Ad-PNM, our adenovector which contains Pdx1,
Ngn3 and MafA coding regions as a single transcription unit,
separated by 2A sequences. The four rat cells were: pancreatic
exocrine cells (AR42J-B13), primary hepatocytes, adult
fibroblasts (CRL-1213) and multipotent adult progenitor cells
(MAPC). The four mouse cells were hepatocyte-derived small
cells (ASH), primary hepatocytes, tail tip fibroblasts and
embryonic fibroblasts (MEF). Three days after viral
transduction the cells were processed for analysis. Three days
was selected as a suitable time point for several reasons.
Previous studies with B13 cells had indicated little change in
response after three days [5]. Some of the cell types, such as
ASH, are highly proliferative and this means that a longer time
period enables the parent cells to overgrow the transformed
ones. Conversely, some of the primary cells, particularly the
primary hepatocytes, show significant cell death beyond three
days culture. For cell characterization, total RNA was isolated
for RT-PCR for a range of beta cell markers (Figure 1), and
cells were fixed for immunostaining (Figure 2). The cells were
co-stained for insulin expression, for the Ad-PNM input gene
products, and for C-peptide.
The level of viral transduction for this set of experiments was
as follows, given as % PDX1-positive ± standard error: AR42j-
B13 96.5±0.19; rat primary hepatocytes 98.7±0.29; rat
fibroblasts 92.6±0.87; rat MAPC 43.8±2.09; mouse ASH
80.2±3.92; mouse primary hepatocytes 98.9±0.69, mouse tail
tip fibroblasts 81.7±3.57; mouse embryonic fibroblasts
66.1±7.38. Cells were also stained for NGN3 and MAFA, which
were found at similar levels to PDX1 (Figure 2A-C).
In all eight cell types used in this study, three days after Ad-
PNM transduction, insulin gene expression was detected by
RT-PCR (rodents have two insulin genes, Ins1 and Ins2)
(Figure 1). In addition to insulin, the most responsive four cell
types (rat primary hepatocytes, rat MAPCs, AR42J-B13 cells
and mouse small hepatocytes) also upregulated some other
important beta cell markers (Figure 1A-D). Rat primary
hepatocytes started to express the beta cell transcription factor
genes Pax4, Isl1 and Mnx1, the beta cell membrane protein
genes Abcc8, Kcnj11 (=Sur2, Kir6.2, encoding components of
the ATP-sensitive K channel, important in insulin secretion),
and Slc2a2 (=Glut2, encoding the β-cell glucose transporter),
the endogenous counterpart of Pdx1, and Cpe
(Carboxypeptidase E, encoding an enzyme important for
proinsulin processing). They also upregulated the gene for Iapp
(islet amyloid polypeptide), and the alpha cell hormone gene
glucagon (Gcg). Rat MAPCs started to express the beta cell
transcription factor genes Pax4, Neurod1, Nkx2.2, Isl1, Mnx1;
the beta cell membrane protein genes Slc2a2, Kcnj11 and
Abcc8. AR42J-B13 cells started to express the beta cell
transcription factor genes Pax4, Neurod1, Nkx2.2; the beta cell
membrane protein gene Abcc8 as well as Cpe and Pcsk2.
Mouse ASH cells started to express the beta cell transcription
factor genes Pax4 and Mnx1, the beta cell membrane protein
genes Slc2a2, Kcnj11 and Abcc8; as well as Cpe and Pcsk2
(Proprotein convertase subtilisin/kexin type 2).They also
expressed the PP-cell hormone gene Ppy (Pancreatic
polypeptide). All these cell types also upregulated Iapp. In
addition to upregulating some of the various beta cell genes,
the various cell types also downregulated the expression of
some of their original specifically expressed genes, including
Pou5f1 (= Oct4) in rat MAPCs, Amy2 (pancreatic amylase) in
AR42J-B13 cells, and Alb (albumin) in mouse hepatocyte-
derived small cells. The other four cell types: rat adult
fibroblasts (CRL-1213), mouse embryonic fibroblasts (MEF),
mouse primary hepatocytes and mouse adult fibroblasts (tail
tip) showed little or no response of the beta cell genes apart
from the insulin genes (Figure 1E-H).
Although insulin gene expression was detected for all the cell
types by RT-PCR, insulin immunostaining was only detected in
five cell types, which are rat primary hepatocytes, mouse
hepatocyte-derived small cells (ASH), AR42J-B13 cells, rat
MAPCs and CRL-1213, and only reliably for the first three
(Figure 2D-L). In addition to insulin, the presence of C-peptide,
which is a product formed during the cleavage of proinsulin to
insulin, and its co-localization with insulin in the same cells,
were also shown for rat primary hepatocytes, mouse
hepatocyte-derived small cells and AR42J-B13 cells (Figure
2F',I',K’).
The qualitative RT-PCR data are summarized in Tables 1
and 2, and counts of insulin-positive cells as a fraction of
transduced cells (Pdx1-positive) are given in Figure 2D. There
was a highly statistically significant difference between groups
as determined by one-way ANOVA (F(4,10) = 59.856, p <
0.001). To confirm where the differences occurred between
groups we performed a Tukey post-hoc test. This test is
appropriate for data showing homogeneity of variances
between groups. It showed a significant difference (p<0.01)
between B13 and each of the other cell types, but a non-
significant difference (p>0.1) between each of the other cell
types with each other.
We also examined the effect of the Ad-PNM transduction on
the division rates of the cells. Ethynyl deoxyuridine (EdU) was
administered three days after Ad-PNM and the cells fixed 18
hours later. The percentage of S-phase cells in the control
populations was compared to the percentage of S-phase cells
among the virus-transduced population (calculated as the
percentage positive for (PDX1+EdU)/PDX1). This indicated a
considerable drop in the proportion of dividing cells for the
AR42j-B13 cells and hepatocytes, but not for the fibroblasts,
maybe because the degree of reprogramming for the
fibroblasts was very limited (Figure 3). For PDX1-positive cells
there was a significant drop in EdU index compared to the
overall score for Ad-PNM transduced plates (t-tests: p<0.05 for
AR42j-B13, ASH and MEF). If only insulin-positive cells are
scored for EdU labeling, then the percentages are very low
(AR42j-B13: 2.89±1.52; rat hepatocytes: 0, ASH cells 0; other
cell types showed insufficient insulin-positive cells for scoring)
suggesting that reprogramming to the beta-like state is not
compatible with continued cell division. Because of this lack of
further division, it is not possible to maintain the insulin-positive
Reprogramming to a Beta-Like State
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Figure 1.  Expression of various beta cell genes provoked by transduction with Ad-PNM.  A-H. Qualitative RT-PCRs showing
the effect of Ad-PNM on the expression of a panel of beta cell genes. 30 cycles were used unless otherwise shown. The misaligned
bands in the first two lanes of mouse fibroblast Mnx1 are primer dimers, not RNA.
doi: 10.1371/journal.pone.0082424.g001
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cells long term. However they have been maintained in viable
but non-dividing form for up to 4 weeks and so we believe that
the reprogramming is stable and not just a transient gene
expression induced by the vector-encoded factors. The
phenotype of the insulin-positive cells derived from the
pancreatic exocrine (AR42j-B13) cells has been characterized
in detail and published separately [5]. That study showed that it
represents a partial transformation toward a beta-cell
phenotype, not a complete one.
Enhancement of reprogramming by small molecules
Although a high proportion of Ad-PNM transduced AR42j-
B13 cells will become immunopositive for insulin, for the rat
hepatocytes and ASH cells the percentage of insulin-positive
cells produced by Ad-PNM is low. We were interested to find
whether adjuvant treatments with small molecule-type
substances could increase the yield. The mouse small
hepatocytes (ASH cells) were chosen to test the effects of 13
different compounds. ASH cells have a number of practical
advantages over primary hepatocytes; they are rapidly
expandable, homogeneous, have a stable phenotype, and are
smaller and less fragile than hepatocytes. Furthermore a
Figure 2.  Insulin-positive cells generated from different cell types.  A,B,C Expression of PDX1, NGN3, MAFA in ASH cells.
The proteins are shown in green, DAPI in blue.
D. Histogram of the percentage PDX1-positive cells which are insulin-positive in different cell types.
E,E’ Rat hepatocytes, some PDX1-positive cells are insulin-positive.
F,F’ Rat hepatocytes, insulin-positive cells are also C-peptide-positive.
G Mouse ASH cells, some PDX1-positive cells are insulin-positive.
H. Mouse ASH cells, showing cytoplasmic location of insulin. Inset, high magnification showing insulin-containing granules.
I,I’ Mouse ASH cells showing co-expression of C-peptide with insulin.
J Rat AR42j-B13 cells showing a high proportion of insulin-positive cells.
K,K’ Rat AR42j-B13 cells showing co-expression of C-peptide with insulin.
L. Rat AR42j-B13 showing insulin-containing granules.
Scale bars 100µm, except H inset and L which are 25 µm. Blue color is DAPI throughout.
doi: 10.1371/journal.pone.0082424.g002
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consistent percentage of cells became insulin-positive following
Ad-PNM treatment. In this series of experiments, 2% of the
ASH cells that were positive for PDX1 were also positive for
insulin. This is a low percentage which easily allows increases
to be detected. We confirmed that all the insulin-positive cells
are PDX1-positive and no insulin-positive cells are ever found
in untransduced cultures.
We chose thirteen different small molecule agents that were
either shown or thought to favor beta cell formation, replication
and/or survival in other systems. We classified them into three
groups: a) chromatin modification agents: trichostatin A (TSA),
valproic acid (VPA), suberoylanilide hydroxamic acid (SAHA),
BIX-01294 (BIX for short, a diazepin-quinazolin-amine
derivative) and 5-azacytosine (5-AzaC); b) signaling/
metabolism agents: pirinixic acid (WY-14643) (an agonist of
PPARα and γ), N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-
phenylglycine t-butyl ester (DAPT) (an inhibitor of Notch),
mycophenolic acid (MPA) (an inhibitor of IMP dehydrogenase
which is used as an immunosuppressant), 5'-N-
ethylcarboxamidoadenosine (NECA) (an agonist of adenosine)
and nicotinamide (precursor of NAD/NADP, and inhibitor of
PARP-1); c) retinoic acid (RA) and the inhibitors of its synthesis
disulfiram (tetraethylthiuram disulphide) and
diethylaminobenzaldehyde (DEAB).
The concentrations used were those that were just below the
level at which detectable cell death was produced over a two
Table 1. Upregulation of gene expression by Ad-PNM in the
four rat cell types.
Pancreatic mRNA AR42j-B13 Hepatocytes CRL-1213 MAPC
rInsulin1 ++++ ++++ + ++
rInsulin2 ++++ ++++ + ++++
rGlucagon - +++ - -
rPanc.Polypeptide - - - -
rSomatostatin - - - -
rIAPP +++ ++++ - ++
rPax4 +++ +++ - ++
rNeuroD C - - +
rNkx2.2 + - - +
rArx +++ - - +
rPdx1 - + + -
rMafA - C - -
rIsl1 - + - +
rMnx1 - ++ - +
rPax6 + + - -
rHes1 C C C C
rGlut2(Slc2a21) - C - +
rKir6.2((Kcnj11) + +++ + +
rSur1(Abcc8) - + - ++
rPtf1a C - - -
rCarboxypeptidaseE +++ ++ C -
rPcsk1 - - - -
rPcsk2 C - - -
++++,+++,++,+ indicate approximate expression levels, - means not detected, C
means present in untreated cells of this type.
doi: 10.1371/journal.pone.0082424.t001
Table 2. Upregulation of genes by Ad-PNM in the four
mouse cell types.
Pancreatic mRNA ASH Hepatocytes Tail tip fibroblasts MEF
mInsulin1 ++++ + + ++
mInsulin2 ++++ - ++ +
mGlucagon - + + -
mPanc.Polypeptide ++ - - -
mSomatostatin - - - -
mIAPP +++ - +++ -
mPax4 ++ - - -
mNeuroD - - - ND
mNkx2.2 - - + -
mNkx6.1 - - - -
mArx C - - -
mPdx1 UTR - - - -
mIsl1 - - - -
mMnx1 + - - -
mPax6 - - - -
mHes1 C C C C
mGlut2 (Slc2a21) C C - -
mKir6.2 (Kcnj11) + - - -
mSur1 (Abcc8) ++ - ++ -
mChromogranin ++++ - - -
mAfp C C - -
mPTF1a - - - -
mCarboxypeptidaseE + - + -
mPcsk1 - - - -
mPcsk2 + - - -
++++,+++,++,+ indicate approximate expression levels, - means not detected, C
means present in untreated cells of this type, ND not determined.
doi: 10.1371/journal.pone.0082424.t002
Figure 3.  EdU labeling index in five cell types.  Those
which generated insulin-immunopositive cells showed a
reduction in EdU label. Errors are standard errors, n=3.
doi: 10.1371/journal.pone.0082424.g003
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day culture. Each of the substances was added to the cells two
days before Ad-PNM addition. Three days after viral
transduction the percentage of insulin-positive cells was
calculated, as a fraction of PDX1-positive cells. Results were
analyzed by one way analysis of variance followed by the
Games-Howell post hoc test (appropriate here because the
variances are not homogeneous). There was a highly
significant difference between groups as determined by one-
way ANOVA (F(14,54) = 22.477, p < 0.001). From the 13
substances screened, three increased to a significant degree
the number of insulin-positive cells as a fraction of the PDX1-
positive cells (Figure 4). These were DAPT (p<0.001), NECA
(p=0.007) and BIX (p=0.049). They yielded respectively ~6% (3
fold increase), ~4% (2 fold increase) and ~4% (2 fold increase).
TSA and 5-azaC reduced the insulin-positive cells but also had
a noticeable toxic effect, even at low concentrations, and
completely stopped the cells from dividing. The other
substances had no significant effect on the yield of insulin-
positive cells.
DAPT, NECA and BIX all exert their biochemical effects by
different mechanisms and therefore we felt that in combination
they should have an additive effect on the number of insulin-
positive cells. When ASH cells were exposed to all three of
these substances at the same time, there was a significant
amount of cell death. After some experimentation, the
concentration of NECA and BIX was reduced to half the
original, with the concentration of DAPT remaining as
previously. So the three substance combination DNB consisted
of DAPT:10µM, NECA:5µM, BIX:1µM. Cells in DNB stayed in
good health and, as shown in Figure 4, showed a significantly
(p=0.006) better response to Ad-PNM than to any of the
substances alone. The proportion of insulin-positive cells under
these conditions was about 12 per cent.
Figure 4.  Effects of the small molecule combination.  A. ASH cells transduced with Ad-PNM, without and with the DNB
combination. PDX1 is immunostained green and insulin red. Scale bar 100µm. B. Percentage of PDX1-positive cells that are also
insulin-positive. Comparisons are by one way ANOVA with Games-Howell post hoc test, * indicates significant enhancement. Errors
are standard errors, n=6.
doi: 10.1371/journal.pone.0082424.g004
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To extend the analysis we carried out a qRT-PCR analysis
using a similar panel of markers to that used for the survey of
cell type susceptibility. From these data (Figure 5A) it can be
seen that the level of Pdx1 and MafA expression is the same in
all three treatment groups; Ad-PNM alone, cells exposed to Ad-
PNM and DAPT, and cells exposed to Ad-PNM and the DNB
combination. This suggests that neither DAPT nor the DNB
combination affect the viral transduction process or the
expression of the viral genes. As we have found above with the
ASH cells, Ad-PNM altered the gene expression pattern
dramatically. Figure 5A shows that both insulin genes were
upregulated and the expression level of some important beta
cell products also increased, for example the transcription
factor genes Isl1,Pax4,Insm1, the genes encoding proteins for
glucose sensing Kcnj11,Abcc8, Gck, the genes encoding
insulin-processing proteins Cpe, Pcsk1&2. However, not all
genes that are known to play an important role in beta cell
function were upregulated, for example mRNAs Nkx2.2 and 6.1
are not elevated. Also worth noting is the lack of endogenous
Pdx1 expression, as this should be present in mature beta
cells. Furthermore the levels of the typical beta cell mRNAs,
relative to Gapdh, are lower than in mouse islet RNA (see
Figure S7C of [6]). Immunostaining for several beta cell
markers other than insulin (MNX1, RFX6, NEUROD and
PAX4 ) gave negative results (data not shown). Overall the
results suggest an incomplete type of reprogramming very
similar to that seen with AR42j-B13 cells [5]. Moreover, the
treatment of ASH cells with DAPT and the DNB combination
does not seem to change the qualitative pattern of gene
expression. The differences from Ad-PNM alone can be
accounted for by the increase in the number of responding
cells.
To detect the amount of insulin protein secreted by the
transformed cells, and to test for any glucose sensitivity, we
Figure 5.  Gene expression in ASH cells provoked by the small molecule combination, with and without Ad-PNM.  A. qRT-
PCR for a panel of beta cell genes. Errors are standard errors, n=3.
B. Insulin secretion in low and high glucose. Comparisons are by 1 way ANOVA with Tukey posthoc test and additional t tests.
doi: 10.1371/journal.pone.0082424.g005
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measured the amount of insulin in the medium by ELISA after
exposure to either low or high glucose (Figure 5B). A one-way
ANOVA followed by Tukey post hoc tests was conducted to
examine the effect on insulin secretion of Ad-PNM, DNB, and
the glucose level in the medium. There was a significant
interaction on insulin secretion from the cells: (F(3, 23)=185.3,
p<0.001). Insulin secretion was mostly due to the presence of
Ad-PNM (p<0.001) with a smaller increase associated with
DNB (p<0.001). There was an additional small elevation due to
the glucose level which just reached statistical significance (t
test: p=0.03 for Ad-PNM alone and 0.032 for Ad-PNM+DNB).
The insulin secretion levels were substantially less than the
value for mouse islets measured in our lab under the same
conditions (2.46ng/µg protein). The insulin content of the cells
(AdPNM+DNB) was measured as 105±7.91 pg/µg protein, also
less than the level for islets (10.97ng/µg protein). These figures
represent the whole cell population, not just the insulin-positive
cells. If there are 12% insulin-positive cells in the culture, as
shown in Figure 4B, then the insulin content per cell would be
about 0.875ng/µg, still less than the islet level. In addition,
although there does appear to be a slight glucose
enhancement of insulin secretion, the enhancement from
mouse islets is much greater, normally about 5 fold.
Discussion
Three days after transduction with Ad-PNM, all cell types
used in this study showed some degree of insulin gene
upregulation by RT-PCR. But this in itself may just be due to a
direct effect of the input transcription factors. In addition to the
insulin genes, some other beta cell genes were upregulated in
four cell types which were rat AR42J-B13 cells, rat primary
hepatocytes, mouse hepatocyte-derived small cells (ASH
cells), and rat MAPCs. In these cell types there was also some
downregulation of their original major product genes.
Immunocytological detection of C-peptide together with insulin
protein in the same cells indicated that the insulin is being
made by the transformed cells rather than simply being
absorbed from the tissue culture medium insulin. This indicates
the ability of the Pdx1, Ngn3 and MafA combination to lead the
transformation of some cell types into a beta cell-like state.
However, in no case was the gene expression profile changed
to a true beta cell phenotype.
In this study we used eight different cell lines from two
different species: rat and mouse. Based on the response of
these cell types to Ad-PNM, the rat pancreatic exocrine cell line
AR42J-B13 cells, rat primary hepatocytes, and mouse ASH
cells showed a significant response to Ad-PNM by activating
many beta cell genes, whereas the three types of fibroblast
upregulated few if any apart from the insulin genes (Figure 1).
The comparisons cannot be conclusive since the levels of
expression of the virus-encoded genes is not exactly the same
and the true identity of cell lines is never certain. However we
believe that the data are consistent with the idea that
competence of cells to give rise to a beta cell-like state is
associated with their existing developmental relatedness to
beta cells. Pancreatic exocrine and endocrine cells arise from
the same progenitor cell population during pancreas
development [11] and only diverge at the final stage before
terminal cell differentiation. Earlier in embryogenesis the liver
and the pancreas arise from neighboring regions of the
definitive endoderm. Different signals from surrounding tissues,
like FGFs from the cardiac mesoderm and BMP from the
septum transversum [12], and activin-βB and FGF2 from the
notochord [13] directs the formation of liver and pancreatic
buds respectively from definitive endoderm. For this reason
pancreatic exocrine cells and hepatocytes may be expected to
share some epigenetic memory with beta cells, such that
various key genes are located in open chromatin, ready to be
turned on in the presence of appropriate transcription factors.
Even though these three cell types did not activate all important
beta cell genes after transduction with Ad-PNM, their higher
response is compatible with the idea that developmentally
related cells show a higher susceptibility to transformation.
Of thirteen small molecule substances used in this study, the
Notch signal blocking agent DAPT gave the best result with a
three-fold increase in the number of insulin-positive cells
compared to those that were induced with Ad-PNM only. This
favorable effect of DAPT was probably due to its ability to
deplete the Notch signal driven-expression of Hes1 which
suppresses pancreatic endocrine cell formation and which is in
most cases reduced by Ad-PNM transduction. Our results for
DAPT are consistent with the studies performed with
developing zebrafish larvae which demonstrated a favorable
effect of DAPT on beta cell formation [14,15].
Among chromatin modifying agents tested here, the G9a
HMT enzyme inhibitor BIX-01294 was the only one which
significantly increased the number of insulin-positive cells. This
was probably due to its effect on lowering H3K9Me2 level,
thereby allowing the active transcription of many genes [16].
The HDAC enzyme inhibitors such as TSA, VPA and SAHA,
however, did not increase the number of insulin-positive cells.
Their effect was different from that reported by [17] in which
HDAC enzyme inhibitors increased the number of endocrine
cells in rat embryo pancreatic bud cultured in vitro.
The adenosine agonist NECA is the other small molecule
agent that resulted in an almost two-fold increase in the
number of insulin-positive mouse hepatocyte-derived small
cells. It has recently been showed that NECA acts through the
adenosine receptor A2aa and increases the proliferation of
beta cells during regeneration in zebrafish[18].
When we used these three most effective small molecules
(DAPT, BIX and NECA) together on the ASH cells, they
increased the number of insulin-positive cells almost six-fold
(overall yield~12%). These three agents have different mode of
actions and targets in the cell so an approximately additive
effect is to be expected.
qRT-PCR and ELISA results demonstrated that there is a
small increase in the expression level of many beta cells genes
as well as in the amount of the insulin released into the
medium from the cells when the DNB combination is used
together with Ad-PNM. However, the increase in the transcript
level as well as the increase of secreted insulin is probably due
simply to an increase in the number of the responding cells.
This is because there is no upregulation of different beta cell
markers in DNB + Ad-PNM samples compared to Ad-PNM
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alone. Also, the increase of secreted insulin in high glucose
compared to a low glucose environment is very small and
much less than real beta cells. We concluded that when used
together with Ad-PNM, the DNB combination can increase the
quantity of transformed cells but not the quality of the
transformation
Our overall conclusions are as follows. Firstly the PNM gene
combination has a number of interesting effects but it does not
reprogram any of the cell types all the way to genuine beta-
cells. Secondly, the partial reprogramming seen may be more
pronounced in developmentally related cell types than in
unrelated types. Thirdly, the three substance combination DNB
gives an enhancement of activity which may prove useful for
this type of reprogramming in future.
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